164 related articles for article (PubMed ID: 32257207)
81.
Saito T; Akaike K; Kurisaki-Arakawa A; Toda-Ishii M; Mukaihara K; Suehara Y; Takagi T; Kaneko K; Yao T
Mol Clin Oncol; 2016 Jan; 4(1):61-64. PubMed ID: 26870359
[TBL] [Abstract][Full Text] [Related]
82. Identification of h-TERT Promoter Mutations in Germline DNA from North Indian Lung Carcinoma Patients.
Prasad R; Panchal S; Rani I; Kishan J; Parashar G
Indian J Clin Biochem; 2023 Jan; 38(1):120-127. PubMed ID: 36684496
[TBL] [Abstract][Full Text] [Related]
83. Pan-cancer experimental characteristic of human transcriptional patterns connected with telomerase reverse transcriptase (
Drobyshev A; Modestov A; Suntsova M; Poddubskaya E; Seryakov A; Moisseev A; Sorokin M; Tkachev V; Zakharova G; Simonov A; Zolotovskaia MA; Buzdin A
Front Genet; 2024; 15():1401100. PubMed ID: 38859942
[TBL] [Abstract][Full Text] [Related]
84. Can TERT rs2853669 polymorphysm indicate fibrosis in sarcoidosis?
Kement S; Turgut Ugurtay E; Tanrıvermis Sayıt A; Tascı P; Unsal M
Sarcoidosis Vasc Diffuse Lung Dis; 2023 Dec; 40(4):e2023043. PubMed ID: 38126504
[TBL] [Abstract][Full Text] [Related]
85. Association of TERT gene polymorphisms with clinical benign prostatic hyperplasia in a Chinese Han population of the Northwest region.
Fan G; Li K; Pang Y; Zhao Y; Tao Y; Gui H; Wang H; Svatek R; Rodriguez R; Wang Z
Transl Androl Urol; 2021 Feb; 10(2):692-702. PubMed ID: 33718071
[TBL] [Abstract][Full Text] [Related]
86. Combining Telomerase Reverse Transcriptase Genetic Variant rs2736100 with Epidemiologic Factors in the Prediction of Lung Cancer Susceptibility.
Wang X; Ma K; Chi L; Cui J; Jin L; Hu JF; Li W
J Cancer; 2016; 7(7):846-53. PubMed ID: 27162544
[TBL] [Abstract][Full Text] [Related]
87. TERT promoter mutations and monoallelic activation of TERT in cancer.
Huang FW; Bielski CM; Rinne ML; Hahn WC; Sellers WR; Stegmeier F; Garraway LA; Kryukov GV
Oncogenesis; 2015 Dec; 4(12):e176. PubMed ID: 26657580
[TBL] [Abstract][Full Text] [Related]
88. Absence of TERT promoter mutations in colorectal precursor lesions and cancer.
Cruvinel-Carloni A; Yamane L; Scapulatempo-Neto C; Guimarães D; Reis RM
Genet Mol Biol; 2018; 41(1):82-84. PubMed ID: 29473934
[TBL] [Abstract][Full Text] [Related]
89. Novel Variant Identified in the Enhancer Region of Host Transcription Factor, BRN3A, is a Significant Risk Factor for HPV-Induced Uterine Cervix Cancer.
Prakash A; Das Purkayastha BP; Srivastava S; Chaturvedi S; Ali A; Aggarwal DD; Roy JK
Int J Mol Cell Med; 2022; 11(2):88-103. PubMed ID: 37091039
[TBL] [Abstract][Full Text] [Related]
90. The Drivers, Mechanisms, and Consequences of Genome Instability in HPV-Driven Cancers.
Porter VL; Marra MA
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230545
[TBL] [Abstract][Full Text] [Related]
91. Anchored Multiplex PCR Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA.
Diefenbach RJ; Lee JH; Stewart A; Menzies AM; Carlino MS; Saw RPM; Stretch JR; Long GV; Scolyer RA; Rizos H
Front Oncol; 2022; 12():820510. PubMed ID: 35494035
[TBL] [Abstract][Full Text] [Related]
92. Human TERT promoter polymorphism rs2853669 is associated with cancers: an updated meta-analysis.
Aziz MA; Jafrin S; Islam MS
Hum Cell; 2021 Jul; 34(4):1066-1081. PubMed ID: 33743166
[TBL] [Abstract][Full Text] [Related]
93. TERT-Regulation and Roles in Cancer Formation.
Dratwa M; Wysoczańska B; Łacina P; Kubik T; Bogunia-Kubik K
Front Immunol; 2020; 11():589929. PubMed ID: 33329574
[TBL] [Abstract][Full Text] [Related]
94. Regulatory Single Nucleotide Polymorphism Increases TERT Promoter Activity in Thyroid Carcinoma Cells.
Hirokawa T; Arimasu Y; Chiba T; Nakazato Y; Fujiwara M; Kamma H
Pathobiology; 2020; 87(6):338-344. PubMed ID: 33227798
[TBL] [Abstract][Full Text] [Related]
95. Clinicopathological significance of the single nucleotide polymorphism, rs2853669 within the TERT promoter in papillary thyroid carcinoma.
Hirokawa T; Arimasu Y; Chiba T; Fujiwara M; Kamma H
Pathol Int; 2020 Apr; 70(4):217-223. PubMed ID: 31943527
[TBL] [Abstract][Full Text] [Related]
96. The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism.
Batista R; Cruvinel-Carloni A; Vinagre J; Peixoto J; Catarino TA; Campanella NC; Menezes W; Becker AP; de Almeida GC; Matsushita MM; Clara C; Neder L; Viana-Pereira M; Honavar M; Castro L; Lopes JM; Carvalho B; Vaz RM; Máximo V; Soares P; Sobrinho-Simões M; Reis RM; Lima J
Int J Cancer; 2016 Jul; 139(2):414-23. PubMed ID: 26914704
[TBL] [Abstract][Full Text] [Related]
97. Human TERT promoter mutations as a prognostic biomarker in glioma.
Powter B; Jeffreys SA; Sareen H; Cooper A; Brungs D; Po J; Roberts T; Koh ES; Scott KF; Sajinovic M; Vessey JY; de Souza P; Becker TM
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1007-1017. PubMed ID: 33547950
[TBL] [Abstract][Full Text] [Related]
98. TERT promoter mutations in thyroid cancer.
Liu R; Xing M
Endocr Relat Cancer; 2016 Mar; 23(3):R143-55. PubMed ID: 26733501
[TBL] [Abstract][Full Text] [Related]
99. Association between functional TERT promoter polymorphism rs2853669 and cervical cancer risk in South Indian women.
Vinothkumar V; Arun K; Arunkumar G; Revathidevi S; Ramani R; Bhaskar LVKS; Murugan AK; Munirajan AK
Mol Clin Oncol; 2020 May; 12(5):485-494. PubMed ID: 32257207
[TBL] [Abstract][Full Text] [Related]
100.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
